Basics Citius Pharmaceuticals, Inc. Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology. IPO Date: June 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $18.21M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 4.27% Avg Daily Range (30 D): $0.12 | 9.44% Avg Daily Range (90 D): $0.08 | 6.66% Institutional Daily Volume Avg Daily Volume: 1.61M Avg Daily Volume (30 D): 4.11M Avg Daily Volume (90 D): 1.56M Trade Size Avg Trade Size (Sh.): 397 Avg Trade Size (Sh.) (30 D): 292 Avg Trade Size (Sh.) (90 D): 280 Institutional Trades Total Inst.Trades: 45 Avg Inst. Trade: $2.78M Avg Inst. Trade (30 D): $6.8M Avg Inst. Trade (90 D): $6.8M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.35M Avg Closing Trade (30 D): $6.8M Avg Closing Trade (90 D): $6.8M Avg Closing Volume: 149.91K     News Jul 16, 2025 @ 1:15 PM Citius Oncology Announces Pricing of $9.0 Million ... Source: Prnewswire Jun 12, 2025 @ 12:35 PM Citius Pharmaceuticals Announces Closing of Regist... Source: Prnewswire Jan 7, 2025 @ 1:08 PM Citius Pharmaceuticals and Citius Oncology Highlig... Source: Prnewswire Jul 31, 2023 @ 7:30 PM Why Apellis Pharmaceuticals Shares Are Trading Lo... Source: Lisa Levin Jul 31, 2023 @ 12:31 PM Why China Natural Resources Shares Are Trading Hig... Source: Lisa Levin Financials   TTM Q2 2025 Q1 2025 Basic EPS $-5.76 $-1.27 $-1.31 Diluted EPS $-5.76 $-1.27 $-1.31 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -43.44M $ -11.51M $ -10.28M Operating Income / Loss $ -42.98M $ -11.26M $ -10.04M Cost of Revenue $ $ $ Net Cash Flow $ -9.31M $ $ PE Ratio     Splits Nov 26, 2024:   1:25 Jun 09, 2017:   1:15 Sep 12, 2014:   5:8